During my master and Ph.D. at Utrecht University, my research concentrated on epidemiology, specifically modeling and analyzing antimicrobial use and resistance across humans, animals, and the environment in nine European countries. In my postdoctoral work at Fudan University and UC San Francisco, my focus shifted to clinical pharmacology, where I investigated the PK profiles and PD characteristics of genomic and TB drugs. This involved developing and applying non-linear pharmacological models to deepen understanding and support drug development efforts.
During my master and Ph.D. at Utrecht University, my research concentrated on epidemiology, specifically modeling and analyzing antimicrobial use and resistance across humans, animals, and the environment in nine European countries. In my postdoctoral work at Fudan University and UC San Francisco, my focus shifted to clinical pharmacology, where I investigated the PK profiles and PD characteristics of genomic and TB drugs. This involved developing and applying non-linear pharmacological models to deepen understanding and support drug development efforts.